CURLF Curaleaf Holdings, Inc.

MIXED Impact: 5/10 6-K
Horizon weeks Filed May 27, 2026 Processed 7d 18h ago SEC 0001756770-26-000050
Notable filing: 6-K
Latest settled — T+5d
CURLF ▲ +7.91% at T+5d
NEUTRAL call ✓ call won +7.91% · α vs SPY +7.44% · entry $9.48 → $10.23
Next anchor: T+20d in 12d
Currently $9.92 · +4.64% from $9.48 entry
Entry anchored
May 27, 2026
via day open
T+1d
+12.66%
call +12.66% · α +12.11%
$10.68
settled 16d ago
T+5d
+7.91%
call +7.91% · α +7.44%
$10.23
settled 10d ago
T+20d
call — · α —
in 12d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Curaleaf announced a 1-for-3 reverse stock split to increase its share price in preparation for a potential uplisting to a major U.S. stock exchange, coinciding with ongoing U.S. cannabis rescheduling developments. The split will be effective on or about June 5, 2026, reducing outstanding shares from ~698.7M to ~232.9M.

Actionable Insight

The reverse stock split is a technical adjustment to position for a potential U.S. exchange uplisting, not a fundamental change. The catalyst to watch is the progress of U.S. cannabis rescheduling — a positive outcome could unlock institutional access and re-rating. Monitor the July 2026 rescheduling hearing for directional clarity.

Key Facts

  • 1-for-3 reverse stock split effective on or about June 5, 2026.
  • Outstanding shares to reduce from ~698,728,008 to ~232,909,336.
  • Split is intended to meet U.S. exchange price criteria for a future uplisting.
  • Split is in consultation with major U.S. stock exchanges and responds to U.S. cannabis rescheduling developments.
  • CEO cited a potential pathway to uplisting following cannabis rescheduling hearings expected to end in July 2026.

Financial Impact

Reduction in share count from ~698.7M to ~232.9M (1-for-3 reverse split). No change to market cap or enterprise value directly, but expected to boost per-share price proportionately.

share countshare price

Risk Factors

  • U.S. exchange uplisting is contingent on regulatory outcomes (cannabis rescheduling) which remain uncertain.
  • Reverse stock splits can carry negative signaling if not accompanied by fundamental improvement.
  • No guarantee the uplisting occurs even after the split.

Market Snapshot

Exchange
OTC
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
92% bullish (12 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001756770-26-000050
Document: a2026-05x26xcuraleafxann.htm0001756770-26-000050
Document: 0001756770-26-000050-index-headers.html0001756770-26-000050
Document: 0001756770-26-000050-index.html0001756770-26-000050
Document: 0001756770-26-000050.txt0001756770-26-000050
8 reports for CURLF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CURLF — sortable, filterable
Type Now
Jun 5, 2026
7d ago
6-K
NEUTRAL ★ 3/10
$3.48 awaiting T+5awaiting T+5$9.92 (+185.06%)
May 27, 2026
16d ago
6-K
MIXED ★ 5/10
$9.48 $10.23▲ +7.91%▲ +7.44%$9.92 (+4.64%)
May 18, 2026
25d ago
6-K
NEUTRAL ★ 4/10
$3.46 $3.31▼ −4.34%▼ −5.95%$9.92 (+186.71%)
May 11, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$3.99 $3.46▼ −13.28%▼ −13.20%$9.92 (+148.62%)
May 5, 2026
5w ago
6-K
NEUTRAL ★ 3/10
$3.48 $3.99▲ +14.66%▲ +12.67%$9.92 (+185.06%)
May 5, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$3.48 $3.99▲ +14.66%▲ +12.67%$9.92 (+185.06%)
May 5, 2026
5w ago
6-K
NEUTRAL ★ 4/10
$3.48 $3.99▲ +14.66%▲ +12.67%$9.92 (+185.06%)
Apr 17, 2026
8w ago
6-K
BULLISH ★ 5/10
$2.72 $3.30▲ +21.32%▲ +20.77%$9.92 (+264.71%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (53h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access